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Influence of human recombinant interleukin-I (hrIL-1) on collagen metabolism was investigated with rabbit uterine cervi- 
cal fibroblasts. Enzyme-linked immunosorbent assays for collagenase and tissue inhibitor of metalloproteinases (TIMP) 
indicated that hrIL-1 participates in both stimulation of procollagenase production and suppression of TIMP synthesis 
by uterine cervical cells. IL-l did not modulate collagen synthesis. In addition, the sensitivity to IL-I of uterine cervix 
from ovariectomized rabbits was augmented by estradiol-17g treatment. Thus it is proposed that IL-I accelerates collage- 
nolysis in the cervical tissue and its effect on uterine cervix is hormonally regulated. 
Recombinant interleukin-la; Procollagenase; Tissue inhibitor of metalloproteinase; Estradiol- 178; (Rabbit uterine cervix) 
1. INTRODUCTION 
Interleukin-1 (IL-l) is known to exert numerous 
biological effects on various target cells [l]. In ad- 
dition to lymphocyte proliferation activity, IL-I 
has been reported to promote the production of 
collagenase [2-41, other matrix metalloproteinases 
[5] and plasminogen activator [6,7] from synovial 
fibroblasts or chondrocytes. Therefore IL-l is con- 
sidered to play an important role in the destruction 
process of articular cartilage in arthritis. Recently 
we have reported that uterine cervical fibroblasts 
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from pregnant rabbits also retain sensitivity to 
IL-l -like factors in macrophage-conditioned 
medium and produce a large amount of col- 
lagenase in response to the conditioned medium 
[8,9]. However, at present, the precise influence of 
IL-1 on the collagenase production has not been 
clarified. This is due to the fact that collagenase 
and its endogenous inhibitor (TIMP) are coor- 
dinately secreted from cells [2,10-121, and in most 
reports, the effect of IL-l on collagenase produc- 
tion has been studied simply by measuring ap- 
parent collagenase activity without consideration 
of the amount of TIMP produced by the cells. In 
order to investigate the influence of IL-l on col- 
lagenase and TIMP production by rabbit uterine 
cervix more precisely, we have measured the actual 
amount of collagenase and TIMP proteins pro- 
duced using specific ELISA for each component. 
Here, we report that hrIL-1 accelerates the pro- 
duction of collagenase and simultaneously 
depresses the biosynthesis of TIMP in rabbit 
uterine cervical fibroblasts, and that the sensitivity 
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of the rabbit uterine cervix to IL-l is modulated by 
estrogen. 
2. MATERIALS AND METHODS 
MEM and DMEM (4.5 g glucose/l) were purchased from 
Grand Island Biological, Co., Grand Island, NY, USA. FCS 
was obtained from Boehringer-Mannheim, GmbH, Mannheim, 
FRG. hrIL-1 (1 x 10’ units/mg) was kindly donated by Dr M. 
Yamada, Research Laboratories, Dainippon Pharmaceutical 
co., Suita, Osaka, Japan. Other reagents used were of 
analytical reagent grade. 
2.1. Culture of uterine cervical fibroblasts and uterine cervical 
explants 
Nippon white rabbits were used for all experiments in this 
series. Uterine cervical fibroblasts were established from rabbits 
at 23-days gestation and maintained in a culture of MEM/lO% 
(v/v) FCS as described previously [8,13]. For the collagenase 
and TIMP production, the culture medium was changed to 
MEM/O.Z% (w/v) LAH after confluence. Uterine cervical ex- 
plants from non-pregnant and ovariectomized rabbits were 
maintained in DMEM as described previously [9,14]. The 
culture media harvested from cell and explant cultures were cen- 
trifuged at 1300 x g and then stored at -20°C until use. 
2.2. Assay for collagenase activity 
Collagenase was assayed by the fibril assay using 
[%]acetylated collagen and the total collagenase activity was 
determined by the activation of procollagenase with trypsin as 
described previously [13]. One unit of collagenase hydrolyzes 
1 pg substrate/min at 37’C. 
2.3. ELBA for procollagenase and TIMP 
Sheep anti-(rabbit synovial procollagenase) antibody was 
prepared as described previously [15]. Procollagenase com- 
plexed with the antibody was determined by using alkaline 
phosphatase conjugated donkey anti-(sheep IgG)IgG in accor- 
dance with standard procedures of ELISA. TIMP was also 
determined by a sandwich enzyme immunoassay set up with a 
pair of the monoclonal antibodies prepared against bovine den- 
tal pulp collagenase inhibitor [ 161 which was recently proved to 
be a TIMP [17]. Rabbit TIMP content was calculated using a 
standard curve for the bovine form, assuming that they both 
had the same affinity for antibodies. 
2.4. Incorporation of fH]proline into collagen and 
tH]thymidine uptake by DNA 
Radiolabeling and determination of the radiolabeled collagen 
were carried out as described previously [ 181. Incorporation of 
[3H]thymidine into DNA was also determined as described in 
the previous paper 1181. 
3. RESULTS AND DISCUSSION 
When the uterine cervical fibroblasts from preg- 
nant rabbits were treated with various amounts of 
hrIL-1, an apparent collagenase activity in culture 
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Fig. 1. Effect of hrIL-1 on the production of procollagenase and 
TIMP by rabbit uterine cervical fibroblasts. Cervical fibroblasts 
from pregnant rabbit were maintained to the confluence as 
described in the text, and then cells were treated with hrIL-1 in 
0.2% (w/v) LAH/MEM. Aliquots (100~1) of the medium 
accumulated from 3 to 5 days culture were assayed for 
collagenolytic activity, collagenase protein and TIMP as 
described in the text. Data are represented as the mean i SD of 
3 dishes. *, ** and ***, significantly different from control (p < 
0.05, 0.01 and 0.001, respectively). (A) Collagenolytic activity; 
(B) collagenase protein and (C) TIMP. 
media increased in a dose-dependent manner 
(fig.lA). The maximal effect was observed at the 
concentration around 0.5 ng/ml. ELISA for pro- 
collagenase demonstrated that hrIL-1 stimulated 
the procollagenase production in a similar dose- 
dependent manner, although the increase of pro- 
collagenase protein was less than that in the col- 
lagenase activity (fig. 1B). Higher apparent 
collagenolytic activity detected in the culture media 
may be due to synergistic effects of collagenask 
and other gelatinolytic metalloproteinases coor- 
dinatedly secreted from the cells as reported by 
others [19,20] as well as due to the decreased syn- 
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thesis of TIMP (see below). Nevertheless, the such physiological changes are attributed to the in- 
results clearly indicated that hrIL-1 directly creased collagenase production and/or to the 
modulates the biosynthesis of procollagenase. modulation of collagen biosynthesis. The effect of 
On the other hand, the treatment of cervical hrIL-1 on collagen synthesis and secretion was 
fibroblasts with hrIL-1 suppressed the production measured by incorporation of [3H]proline to 
of TIMP to about 205’0 of the control as shown in bacterial collagenase-sensitive intracellular and ex- 
fig.lC. With human fetal lung fibroblasts, tracellular proteins. Table 2 shows that hrIL-1 did 
however, IL-I has been shown to increase the not alter either synthesis or secretion of collagen in 
biosynthesis of TIMP in parallel to procollagenase cervical fibroblasts. Neither was noncollagenous 
production [2]. This discrepancy may be due to the protein synthesis affected by hrIL-1 treatment. 
difference in species of cell types, i.e., rabbit Regulation of sensitivity of rabbit uterine cervix 
uterine cervical vs. human fetal lung fibroblasts. against IL-l was also examined by using cervical 
It has been reported that IL-l regulates the pro- explant cultures of ovariectomized, ovariecto- 
liferation of fibroblasts [21], but its precise effect mized-estrogen primed and non-pregnant rabbits. 
has not been clarified yet since the IL-l prepara- As shown in fig.2, hrIL-1 stimulated all three 
tion used was a partially purified material. We ex- groups of explants to produce increased amounts 
amined, therefore, the influence of hrIL-1 on the of collagenase activity. However, the increased 
proliferation of cervical fibroblasts by measuring levels of collagenase activity in ovariectomized 
the incorporation of [3H]thymidine into DNA. As rabbit primed with estradiol-17fi were 3-times 
shown in table 1, hrIL-1 did not exert any effect on greater than those of ovariectomized- or non- 
the proliferation of cervical fibroblasts both at pregnant rabbits. Another set of experiments con- 
growth and stationary phases. A similar observa- firmed the effect of estradiol-17,6 on IL-l sensitivi- 
tion was reported with rat costal chondrocytes ty. The cervices from ovariectomized-estrogen- 
WI. primed rabbits were effectively stimulated by 
During the uterine cervical ripening and dila- 
tion, most obvious changes are the increase in 
tissue collagenase and decrease in collagen concen- 
tration [23-251. Therefore, we examined whether 
Table 2 
Effect of hrIL-1 on the synthesis of collagen by rabbit uterine 
cervical fibroblasts 
Table 1 
Effect of hrIL-1 on the proliferation of rabbit uterine cervical 
fibroblasts 
hrIL-1 Collagen Noncolla- Ratio of 
(ng/ml) (dpm x genousprotein collagen 
10e4/dish) (dpm x 10m4/ (%) 
dish) 
Group [‘H]Thymidine incorpora- 
tion into DNA 
(dpm x 10-3/well) 
Expt I (growth phase) 
Control 7.7 + 0.6 
hrIL-1 8.6 zk 1.5 
Expt II (stationary phase) 
Control 35.8 + 3.9 
hrIL-1 37.5 * 2.7 
Uterine cervical fibroblasts from rabbit with 23 days gestation 
were suspended at densities of 8 x 104 cells/l.5 ml of 10% (v/v) 
FCWMEM and plated in 35 mm dish. Expt I: 2 days later, the 
medium was changed to 1% (v/v) FCWMEM and cells were 
treated with hrIL-1 (50 ng/ml) for 2 days and then labeled with 
1 &i/ml of [3H]thymidine for final 3 h. Expt II: Cells were 
grown in 10% (v/v) FCWMEM to confluence, then cells were 
treated with hrIL-1 and labeled with [‘Hlthymidine as in expt 
I. Data are shown as the mean f SD of 4 dishes 
Cell: 
Control - 3.5 t 0.3 39.4 + 1.8 1.62 + 0.08 
hrIL-1 50 3.5 + 0.1 40.6 f 2.0 1.57 f 0.08 
100 3.3 * 0.1 37.5 * 1.3 1.58 f 0.04 
Medium: 
Control - 5.0 + 0.2 7.4 + 0.1 11.23 k 0.57 
hrIL-1 50 5.6 + 0.1 7.1 + 0.1 13.27 + 0.59 
100 5.0 f. 0.1 6.1 f 0.2 13.04 + 0.53 
Cervical fibroblasts were suspended and plated as described in 
table 1, and grown to the confluence in 10% (v/v) FCS/MEM, 
and then cells were treated with hrIL-1 for 2 days. The medium 
was then changed to serum-free/MEM/O.l mM ascorbate/0.5 
pM ,&-aminopropionitrile containing hrIL-1 and cells were 
labeled with 7,uCVml of [3H]proline for 4 h. Collagen and 
noncollagenous protein were determined by the digestion with 
purified bacterial collagenase. Ratio of collagen was calculated 
with the assumption that the collagen has an imino acid content 
5.4-fold higher than that of other proteins. Data shown are as 
the mean f SD of 4 dishes 
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Fig.2. Effect of estradiol-17fl priming in vivo on 
hrlL-l-dependent increase in collagenase production by rabbit 
uterine cervix. Rabbits were bilaterally ovariectomized and 
after 4.5 months of the ovariectomy they were primed with 
estradiol-17/3 (100 fig/rabbit, SC) once daily for 7 days. On the 
eighth day cervical tissue was removed and cultured in DMEM 
as described in the text. Tissue explants were cultured with or 
without hrlL-1 (50 ng/ml) in media changed daily for 4 days. 
Aliquots (100 ~1) of the medium were assayed for collagenase 
activity. Data are shown as the mean + SD of 3 dishes. *, ** 
and ***, significantly different from each control 0, < 0.05, 
0.01 and 0.001, respectively). (0) or (o), ovariectomized rabbit 
with or without hrlL-1; (0) or (m), ovariectomized rabbit 
primed with estradiol-17P with or without hrlL-1; and (A) or 
(A), non-pregnant rabbit with or without hrlL-1. 
hrIL-1 and produced a large amount of col- 
lagenase, but in this experiment ovariectomized 
rabbits without estrogen-priming did not retain the 
sensitivity to IL-l (not shown). These results sug- 
gest that the sensitivity against IL-l in the uterine 
cervix is hormonally controlled by estradiol-17,8. 
Biological effects of IL-l are considered to be ex- 
pressed via the binding of IL-l to receptors, and 
IL-l receptors have been found in various IL-l 
target cells [26,27]. Although the exact mechanism 
is yet to be investigated, the expression of cell sur- 
face IL-l receptors in uterine cervix may be 
regulated by estrogen. 
In conclusion, IL-l participates in collagenolysis 
in rabbit uterine cervix by stimulating collagenase 
production and suppressing TIMP synthesis. The 
sensitivity to IL-l of this tissue was augmented by 
estradiol-17,&, suggesting that degradation of col- 
lagen during cervical ripening and dilation is hor- 
monally regulated. 
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